Key result
Acute moderate hypoxia cuts single-leg peak power ~17% vs normoxia despite increased peak cardiac output.
Why the study?
Whether moderate altitude allows cardiac output to increase during single-leg cycling, thereby restoring peak oxygen uptake, has not been extensively investigated.
Does moderate hypoxia reduce one-legged cycling performance compared to normoxia in healthy subjects?
Does moderate hypoxia reduce one-legged cycling performance compared to normoxia in healthy subjects?
Standardized Mean Difference: 4.8
Absolute Event Rate: 128% vs 154%
p-value: p=0.03
Acute moderate hypoxia reduces single-leg cycling performance and oxygen uptake in healthy subjects despite a compensatory increase in peak cardiac output.
Findings in healthy subjects should not change practice; leaves open compensatory mechanisms in clinical hypoxia.
In severe hypoxia, single-leg peak oxygen uptake (VO2peak) is reduced mainly due to the inability to increase cardiac output (CO). Whether moderate altitude allows CO to increase during single-leg cycling, thereby restoring VO2peak, has not been extensively investigated. Five healthy subjects performed an incremental, maximal, two-legged cycle ergometer test, and on separate days a maximal incremental one-leg cycling test in normoxia and in moderate hypoxia (fraction of inspired oxygen (FiO2) = 15%). Oxygen uptake, heart rate, blood pressure responses, power output, and CO (PhysioFlow) were measured during all tests. Moderate hypoxia lowered single-leg peak power output (154 ± 31 vs. 128 ± 26 watts, p = 0.03) and oxygen uptake (VO2) (36.8 ± 6.6 vs. 33.9 ± 6.9 mL/min/kg, p = 0.04), despite higher peak CO (16.83 ± 3.10 vs. 18.96 ± 3.59 L/min, p = 0.04) and systemic oxygen (O2) delivery (3.37 ± 0.84 vs. 3.47 ± 0.89 L/min, p = 0.04) in hypoxia compared to normoxia. Arterial–venous O2 difference (a–vDO2) was lower in hypoxia (137 ± 21 vs. 112 ± 19 mL/l, p = 0.03). The increases in peak CO from normoxia to hypoxia were negatively correlated with changes in mean arterial pressure (MABP) (p < 0.05). These preliminary data indicate that the rise in CO was not sufficient to prevent single-leg performance loss at moderate altitude and that enhanced baroreceptor activity might limit CO increases in acute hypoxia, likely by reducing sympathetic activation. Since the systemic O2 delivery was enhanced and the calculated a–vDO2 reduced in moderate hypoxia, a potential diffusion limitation cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Gatterer et al. (2021) studied Healthy subjects (n=5). Acute moderate hypoxia vs. Normoxia (FiO2 = 20.9%) was evaluated on Single-leg peak power output (Cohen's d 4.8, p=0.03). Acute moderate hypoxia significantly reduced single-leg peak power output by 26 watts compared to normoxia, despite a compensatory increase in peak cardiac output.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: